Frankfurt - Delayed Quote EUR
GH Research PLC (1KA.F)
10.70
-0.90
(-7.76%)
At close: June 13 at 9:15:05 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-41,262
-42,285
-33,336
-26,199
-15,283
Investing Cash Flow
68,185
65,135
-54,100
-84,688
-104
Financing Cash Flow
140,625
-304
-204
0
286,447
End Cash Position
245,031
100,791
78,420
165,955
276,776
Capital Expenditure
-41
-49
-100
-67
-104
Issuance of Capital Stock
150,000
0
15
0
309,200
Repayment of Debt
-233
-304
-219
0
0
Free Cash Flow
-41,303
-42,334
-33,436
-26,266
-15,387
12/31/2021 - 7/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9VC.MU ATAI Life Sciences NV
1.9300
-2.18%
9VC.DE Atai Life Sciences N.V.
1.8545
-2.83%
9VC.F Atai Life Sciences N.V.
1.7920
-1.86%
NEUP Neuphoria Therapeutics Inc.
6.82
-5.40%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
CYBN Cybin Inc.
8.35
-3.47%
ATAI Atai Life Sciences N.V.
2.1100
-3.21%
EYEN Eyenovia, Inc.
2.4400
-8.61%